Yono, Japan

Takamichi Sato


Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Yono, JP (2002 - 2006)
  • Tokyo, JP (2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takamichi Sato: Innovator in Cancer Therapeutics

Introduction

Takamichi Sato is a prominent inventor based in Yono, Japan. He has made significant contributions to the field of cancer therapeutics, holding a total of 3 patents. His work focuses on innovative approaches to diagnosing and treating cancer, particularly through the development of monoclonal antibodies and gene therapies.

Latest Patents

Among his latest patents is the development of an anti-single-chain type IV collagen polypeptide antibody. This pharmaceutical drug serves as a diagnostic, preventive, or therapeutic agent for tumors containing the antibody. The monoclonal antibody specifically binds to a single-chain type IV collagen polypeptide and is derived from a hybridoma line of Anti NK-Antigen monoclonal antibody #141, which has Accession No: FERM BP-11300. Another notable patent involves a gene encoding the promoter domain of the tumor suppressor gene P51. This gene is capable of inducing cell death and is instrumental in diagnosing and treating diseases, including cancer, caused by abnormal cell propagation. The invention also includes antisense DNAs and RNAs, nucleic acid probes, and methods for screening drugs related to these genes.

Career Highlights

Takamichi Sato has worked with notable companies such as Nippon Kayaku Kabushiki Kaisha and Toshiyuki Sakai. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Some of his notable coworkers include Seiichi Saito and Masashi Nagai. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.

Conclusion

Takamichi Sato's contributions to cancer therapeutics through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in the diagnosis and treatment of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…